Ionis to present at the Cowen Annual Health Care Conference

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) will engage in a panel discussion focused on orphan neurological disease therapeutics at the upcoming Cowen 42nd Annual Health Care Conference. The event is scheduled for 9:10 a.m. ET on March 7, 2022. Interested parties can access a live webcast on the company's Investors & Media section of their website, with a replay available for a limited time. Ionis boasts over 30 years in RNA-targeted therapy, including three marketed medicines and a robust late-stage pipeline that emphasizes neurological and cardiometabolic franchises.

CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a panel discussion on orphan neurological disease therapeutics at the virtual Cowen 42^nd Annual Health Care Conference at 9:10 a.m. ET on Monday, March 7, 2022.

A live webcast of this presentation can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. A replay will be available for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully-integrated biotechnology company.

To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-the-cowen-annual-health-care-conference-301492185.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

What is Ionis Pharmaceuticals discussing at the Cowen Conference on March 7, 2022?

Ionis Pharmaceuticals will participate in a panel discussion on orphan neurological disease therapeutics.

What time will Ionis Pharmaceuticals' presentation take place during the Cowen Conference?

The presentation is scheduled for 9:10 a.m. ET on March 7, 2022.

Where can I watch Ionis Pharmaceuticals' presentation at the Cowen Conference?

The live webcast can be accessed on the Investors & Media section of Ionis Pharmaceuticals' website.

How long has Ionis Pharmaceuticals been in the RNA-targeted therapy field?

Ionis Pharmaceuticals has been a leader in RNA-targeted therapy for over 30 years.

What are the main focuses of Ionis Pharmaceuticals' pipeline?

Ionis Pharmaceuticals has a premier late-stage pipeline emphasizing neurological and cardiometabolic franchises.